Researchers from the Centers for Disease Control and Prevention found that while rapid influenza diagnostic test could accurately detect the virus in high concentrations, reverse real-time PCR testing should be done if a definitive determination is needed.

"We had gotten an increasing number of inquiries from physicians wanting to know if the rapid test would work at all on this novel strain, and, of course, off-shot of that is wondering what the sensitivity and specificity would be," says Michael Shaw, associate director for laboratory science in the CDC's influenza division.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

ScienceInsider reports that a new security policy at the US Food and Drug Administration may prevent foreign nationals from working there.

WBUR in Boston looks into Orig3n's genetic fitness assessments to find more research is needed.

Cleveland.com reports that getting a DNA profile removed from a law enforcement database can be tricky.

In PNAS this week: de novo mutations contribute to non-syndromic craniosynostosis, fungal tree of life, and more.